CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-03 | Eldessouky Sam EVP & Chief Financial Officer | Shares withheld for taxes | −1,242 | $23.61 | $29K | 119,455 |
| 2022-02-27 | Eldessouky Sam EVP & Chief Financial Officer | Option exercise | +8,674 | 125,531 | ||
| 2022-02-27 | Eldessouky Sam EVP & Chief Financial Officer | Shares withheld for taxes | −3,102 | $24.35 | $76K | 122,429 |
| 2022-02-27 | Eldessouky Sam EVP & Chief Financial Officer | Shares withheld for taxes | −918 | $24.35 | $22K | 120,697 |
| 2022-02-27 | Eldessouky Sam EVP & Chief Financial Officer | Grant or award · Restricted Share Units | +8,674 | 0 | ||
| 2022-02-27 | Eldessouky Sam EVP & Chief Financial Officer | Option exercise · Restricted Share Units | −8,674 | $24.35 | $211K | 0 |
| 2022-02-26 | Eldessouky Sam EVP & Chief Financial Officer | Shares withheld for taxes | −814 | $24.35 | $20K | 121,615 |
| 2021-06-11 | Eldessouky Sam EVP & Chief Financial Officer | Sale | −17,000 | $31.68 | $539K | 116,857 |
| 2021-06-01 | Eldessouky Sam EVP & Chief Financial Officer | Grant or award | +33,673 | 133,857 | ||
| 2021-06-01 | Eldessouky Sam EVP & Chief Financial Officer | Grant or award · Non-Qualified Stock Options (right to purchase) | +122,427 | $32.03 | $3.9M | 122,427 |
| 2021-03-10 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −7,361 | $32.97 | $243K | 100,184 |
| 2021-03-08 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Option exercise | +4,404 | 94,015 | ||
| 2021-03-08 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Grant or award | +13,530 | 107,545 | ||
| 2021-03-08 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Units | −4,404 | 0 | ||
| 2021-03-03 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Grant or award | +10,298 | 89,611 | ||
| 2021-03-03 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Grant or award · Non-qualified Stock Options (right To Purchase) | +16,374 | 16,374 | ||
| 2021-03-01 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −1,739 | $31.42 | $55K | 79,313 |
| 2020-03-09 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −1,749 | $20.96 | $37K | 81,052 |
| 2020-02-28 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −869 | $24.44 | $21K | 82,801 |
| 2020-02-26 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Grant or award | +6,753 | 83,670 |
Page 1 of 2 · 27 trades